192 results on '"Rogers, Thomas E."'
Search Results
2. Siting and Performance Assessment of Micro Wind Turbines in the Built Environment
3. Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results
4. Development of CD3 cell quantitation algorithms for renal allograft biopsy rejection assessment utilizing open source image analysis software
5. Whole Slide Imaging for Analytical Anatomic Pathology and Telepathology: Practical Applications Today, Promises, and Perils
6. Novel Chiral High-Performance Liquid Chromatographic (HPLC) Determination of MB-102, A New Fluorescent Tracer Agent Enabling the Measurement of Point-of-Care Glomerular Filtration Rate
7. The reduction of Na/H exchanger-3 protein and transcript expression in acute ischemia–reperfusion injury is mediated by extractable tissue factor(s)
8. Bartonella and Rickettsia from Fleas (Siphonaptera: Ceratophyllidae) of Prairie Dogs (Cynomys Spp.) from the Western United States
9. Novel Chiral High-Performance Liquid Chromatographic (HPLC) Determination of MB-102, A New Fluorescent Tracer Agent Enabling the Measurement of Point-of-Care Glomerular Filtration Rate.
10. Studies on the Endocommensal Ciliate Fauna of Caribbean Sea Urchins
11. Change in Prostate Specific Antigen Following Androgen Stimulation is an Independent Predictor of Prostate Cancer Diagnosis
12. How do roads affect the habitat use of an assemblage of scavenging raptors?
13. A Host Lipase Detoxifies Bacterial Lipopolysaccharides in the Liver and Spleen
14. R-Isomers of Arg-Gly-Asp (RGD) mimics as potent α vβ 3 inhibitors
15. Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective α vβ 3 inhibitor: Design, synthesis, and optimization
16. Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C
17. Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin
18. Effectiveness of MB-102, a novel fluorescent tracer agent, for conducting ocular angiography in dogs
19. Prognostic Value of Ishak Fibrosis Stage: Findings From the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
20. Hereditary haemorrhagic telangiectasia involving the bone marrow and liver
21. The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B–dependent hepatotoxicity
22. Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis
23. Power booster
24. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension
25. Extramedullary Sites of Involvement in Hematologic Malignancies: CASE 1. MULTIFOCAL INTRACRANIAL INVOLVEMENT WITH MANTLE-CELL LYMPHOMA
26. A highly stereoselective Michael addition to an alpha, beta-unsaturated ester as the crucial step in the synthesis of a novel beta-amino acid-containing fibrinogen receptor antagonist
27. Chapter 20. Cell Adhesion Integrins as Pharmaceutical Targets
28. VATS Resection of Large Ectopic Posterior Mediastinal Cystic Parathyroid Adenoma
29. Transdermal fluorescence detection of a dual fluorophore system for noninvasive point-of-care gastrointestinal permeability measurement
30. P200 Renal allograft chronic active inflammation/rejection: analysis of banff ti and i-IFTA lesions in a contemporary biopsy cohort
31. Su2049 – Noninvasive Point-Of-Care Measurement of Gut Permeabiltiy in a Rat Indomethacin Injury Model
32. Noninvasive point-of-care measurement of gastrointestinal permeability
33. Collapsing glomerulopathy: A cause of noncardiogenic pulmonary edema
34. Histologic evidence of the safety of endoscopic saphenous vein graft preparation
35. Development of CD3 cell quantitation algorithms for renal allograft biopsy rejection assessment utilizing open source image analysis software
36. Measurement of gut permeability using fluorescent tracer agent technology
37. Measurement of Gut Permeability Using Fluorescent Tracer agent Technology
38. Noninvasive point-of-care measurement of gastrointestinal permeability.
39. Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients
40. Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes
41. Renal Medullary and Cortical Correlates in Fibrosis, Epithelial Mass, Microvascularity, and Microanatomy Using Whole Slide Image Analysis Morphometry
42. Application of fluorescent tracer agent technology to point-of-care gastrointestinal permeability measurement
43. Prognostic Value of Ishak Fibrosis Stage: Findings from the HALT-C Trial
44. Sa2030 - Measurement of Gut Permeability Using Fluorescent Tracer agent Technology
45. Repowering at urban site lifts efficiency, betters environment
46. Pilot-Plant Preparation of an αvβ3 Integrin Antagonist. Part 3. Process Research and Development of a Diisopropylcarbodiimide and Catalytic 1-Hydroxybenzotriazole Peptide Coupling
47. R-Isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors
48. Association of Bartonella with the fleas (Siphonaptera) of rodents and bats using molecular techniques
49. Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective αvβ3 inhibitor: Design, synthesis, and optimization
50. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.